From GlobeNewswire: 2025-06-09 02:00:00

AB Science has received approval from the European Medicine Agency to extend the shelf-life of its veterinary medicine MASIVET® from 36 months to 48 months. MASIVET® is used to treat non-resectable dog mast cell tumors and is currently available in all EU countries. This extension provides more flexibility for patients, caregivers, and the company to manage inventory levels and reduce the risk of product expiration. AB Science specializes in protein kinase inhibitors and is headquartered in Paris, France. MASIVET® is their lead compound, developed for use in both veterinary and human medicine.



Read more at GlobeNewswire: AB Science announces EMA approval of Masivet shelf-life